To this end, the Alzheimer's Disease Neuroimaging Initiative (ADNI), established by America's National Institutes of Health (NIH) in 2004, is measuring the levels of certain proteins in the cerebrospinal fluid of people who may have Alzheimer's or may go on to develop it.

ECONOMIST: Alzheimer's disease